Copyright
©The Author(s) 2017.
World J Cardiol. Jun 26, 2017; 9(6): 481-495
Published online Jun 26, 2017. doi: 10.4330/wjc.v9.i6.481
Published online Jun 26, 2017. doi: 10.4330/wjc.v9.i6.481
Criteria | Level of recommendation | Differences between guidelines | |
ESC/EACTS | AHA/ACC | ||
Severe AS with any symptoms clearly due to AS, based on history or unmasked by stress test | I | I | "High-gradient" in AHA/ACC guidelines |
Asymptomatic severe AS with LVEF < 50% | I | I | |
Severe AS and another indication for surgery (CABG, thoracic aorta, another valve) | I | I | |
Asymptomatic severe AS where the systolic blood pressure does not increase by > 20 mmHg or drops compared with baseline during the treadmill test | IIa | IIa | AHA/ACC guidelines acknowledge the presence of fatigability during stress test as an indication for AVR |
Moderate AS and another indication for surgery (CABG, thoracic aorta, another valve) | IIa | IIa | |
Low-flow/low-gradient/low-LVEF severe AS with proof of contractile reserve presence | IIa | IIa | |
Symptomatic low-flow/low-gradient/preserved LVEF severe AS after careful confirmation of severity | IIa | IIa | |
Truly asymptomatic severe AS (no symptoms during treadmill test, no risk criteria) with preserved LVEF if the surgical risk is deemed low and the following criteria are also satisfied: Very severe AS (maximal velocity ≥ 5.5 m/s); Severe valvular calcification and increased maximal velocity by ≥ 0.3 m/s per year | IIa | IIa for velocity ≥ 5 m/s (see text) | AHA/ACC guideline: Velocity ≥ 5 m/s or mean gradient ≥ 60 mmHg AND severe calcifications; velocity 4 to 4.9 m/s or mean gradient 40 to 59 mmHg AND severe valvular calcification AND stress test demonstrating reduced tolerance or drop in blood pressure |
IIb for maximal velocity increase by ≥ 0.3 m/s per year | |||
Truly asymptomatic severe AS (no symptoms during treadmill test, no risk criteria) with preserved LVEF if the surgical risk is deemed low and 1 or more of the following criteria are also satisfied: Severely increased BNP/Nt-ProBNP levels at serial determinations and without an alternative explanation; increased transaortic pressure gradient at stress echocardiography by > 20 mmHg; excessive LV hypertrophy without an alternative explanation | IIb | - | This indication is not covered in the AHA/ACC guidelines |
Low-flow/low-gradient/low-LVEF severe AS without contractile/flow reserve | IIb | - | This indication is not covered in the AHA/ACC guidelines |
- Citation: Mǎrgulescu AD. Assessment of aortic valve disease - a clinician oriented review. World J Cardiol 2017; 9(6): 481-495
- URL: https://www.wjgnet.com/1949-8462/full/v9/i6/481.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i6.481